FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experience.
about
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesSystematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic CancerA rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancerComplete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and reviewCalpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions.What treatment in 2017 for inoperable pancreatic cancers?FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience.Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.Early decrement of serum carbohydrate antigen 19-9 predicts favorable outcome in advanced pancreatic cancer.Long-term Disease-free Survival Following Combination Multi-visceral and Metastatic Resection with Neoadjuvant FOLFIRINOX for Pancreatic Adenocarcinoma: A Case Report.A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review.A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers.FOLFIRINOX Chemotherapy in Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Retrospective and Phase II Studies.Treatment of pancreatic cancer with intravenous vitamin C: a case report.Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer.Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
P2860
Q26799714-0DB48FD0-5282-4526-ADDC-EB894EF22556Q28072210-8103F222-359F-44D2-A376-0BA995D510FDQ30669159-18201FD8-02A8-45BA-A429-F6E1AD044E73Q33895614-448CAE57-9C11-4EB1-A372-53A2549A3BE8Q35674826-3DB57FCF-A850-40ED-9428-83200BD06995Q36159880-F47A4D95-A96E-47F5-AD10-70F2A6C7AE0EQ37375232-298A111C-BE8F-4548-9A90-D4E6D46BDF00Q38413842-DA498BA6-26E7-4334-B6C2-2581946352A0Q38637958-EC37EAA8-23F4-47AF-98ED-BB55AAEF5258Q38689025-A328A20B-EA6F-4264-8B63-265D8D7C089FQ38829982-77FD614D-6480-4F89-ACFD-3E68241A0D5AQ38910968-FFBAD8CA-B723-494B-82E6-E287164EBC3AQ39023169-C2144A2C-AC6C-4D53-B17E-0FDC3AEEBD9DQ39034733-7E446F1A-0D07-4D7B-946F-DCC813D60FEAQ39151780-E0E13313-5693-4206-A141-1FCBCF8C7212Q41506388-C4FAF508-5F39-4BF3-9566-61FFD4B8580BQ41820976-93630B29-5913-4C24-858D-2E0DC3B1CCF1Q47163065-E503FFED-6FF6-48ED-A5BF-88BFC0B3C1B8Q48293161-E47F9610-E514-4EBA-97B8-E1917DB35032Q48310725-24D1A2D5-31B6-446F-86D4-3F9A2087E0ABQ50042500-6386D9F8-2796-430A-A623-8A3E4D07BAADQ52672976-CBB62685-5087-446F-85D4-468F164C6537Q52673084-6DE0006B-25DE-457C-A64F-9C250EC354D9Q53352724-EE0C7BE4-D34C-40A7-8458-A0C0367D295EQ55190760-426DDC59-1668-4E68-A6F0-104E638A6C3EQ59137774-55515A78-729C-4B4A-87AC-CA96CB745B63
P2860
FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: the Royal Marsden experience.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@ast
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@en
type
label
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@ast
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@en
prefLabel
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@ast
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@en
P2093
P1476
FOLFIRINOX for locally advance ...... the Royal Marsden experience.
@en
P2093
Clare Peckitt
David Watkins
Khurum Khan
Sheela Rao
P304
P356
10.1016/J.CLCC.2014.09.005
P407
P577
2014-09-21T00:00:00Z